HARVARD BIOSCIENCE, INC. Defined Benefit Plan, Plan Assets, Benefits Paid
HARVARD BIOSCIENCE, INC. (HBIO) reported Defined Benefit Plan, Plan Assets, Benefits Paid of $563.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-07.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid · last filed 2024-03-07
- HARVARD BIOSCIENCE, INC. defined benefit plan, plan assets, benefits paid for fiscal 2023 was $563.00K, a 4.90% decline from fiscal 2022.
- HARVARD BIOSCIENCE, INC. defined benefit plan, plan assets, benefits paid for fiscal 2022 was $592.00K, a 18.88% increase from fiscal 2021.
- HARVARD BIOSCIENCE, INC. defined benefit plan, plan assets, benefits paid for fiscal 2021 was $498.00K, a 4.62% increase from fiscal 2020.
- HARVARD BIOSCIENCE, INC. defined benefit plan, plan assets, benefits paid for fiscal 2020 was $476.00K, a 6.49% increase from fiscal 2019.
| Period end | Defined Benefit Plan, Plan Assets, Benefits Paid 12 month |
|---|---|
| 2023-12-31 | $563.00K 10-K · filed 2024-03-07 |
| 2022-12-31 | $592.00K 10-K · filed 2024-03-07 |
| 2021-12-31 | $498.00K 10-K · filed 2023-03-09 |
| 2020-12-31 | $476.00K 10-K · filed 2022-03-11 |
| 2019-12-31 | $447.00K 10-K/A · filed 2021-03-17 |
| 2018-12-31 | $521.00K 10-K · filed 2020-03-16 |
| 2017-12-31 | $514.00K 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |